Raise Money for Throat Cancer Treatment

Your fundraiser on PavelAndreev.ORG starts in three quick and easy steps:

Start a campaign

How to start a throat cancer treatment fundraiser?

At PavelAndreev.ORG we use new technologies to let you support fundraising campaigns quickly and easily.

Create a campaign

Start your throat cancer treatment fundraising campaign in minutes with simple crowdfunding platform instructions.

Admin review & support

A platform administrator will review your throat cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your throat cancer treatment fundraising campaign on social media and receive donations from people who care.

Create a campaign

Start your throat cancer treatment fundraising campaign in minutes with simple crowdfunding platform instructions.

Admin review & support

A platform administrator will review your throat cancer treatment campaign and help you prepare it in the best possible way.

Share & launch

Share your throat cancer treatment fundraising campaign on social media and receive donations from people who care.

Start a campaign

Types of Costs in Throat Cancer Treatment

  • Diagnostic and Staging Costs: Expenses for diagnostic workups, including positron emission tomography/computed tomography (PET/CT), chest CT, magnetic resonance imaging (MRI), Panorex dental X-rays, panendoscopy under anesthesia, biopsies, and biomarker testing (such as HPV/p16 or circulating tumor HPV DNA).
  • Primary Surgical Costs: Costs for operative procedures, including tumor resections, neck dissections, mandibulectomies, partial/total laryngectomies, and pharyngectomies.
  • Radiation Therapy Delivery Costs: Costs for delivering radiation, encompassing Intensity-Modulated Radiation Therapy (IMRT), Intensity-Modulated Proton Therapy (IMPT), Stereotactic Ablative Radiotherapy (SABR/SBRT), brachytherapy, re-irradiation, and dose-reduced/de-escalated radiation protocols.
  • Systemic Therapy Pharmacotherapy Costs: Direct pharmaceutical expenses for platinum-based chemotherapy (e.g., cisplatin, carboplatin), EGFR-targeted monoclonal antibodies (e.g., cetuximab), PD-1/PD-L1 immune checkpoint inhibitors (e.g., pembrolizumab, nivolumab), and antibody-drug conjugates (ADCs).
  • Supportive & Symptom Management Medication Costs: Pharmacological expenses for managing side effects, such as opiate analgesics, antiemetics, antibiotics, PENTOCLO protocol oral regimens, and hematopoietic growth factors.

  • Pre-Treatment & Prehabilitation Costs: Baseline evaluations, preoperative dental restoration and tooth extractions, nutritional optimization, and prehabilitation interventions (e.g., respiratory, muscle, and physical training prior to surgery or chemoradiation).
  • Acute / Definitive Treatment Phase Costs: Inpatient hospital stay costs during major resections, delivery of acute primary chemoradiotherapy regimens, and management of acute treatment toxicities (e.g., severe mucositis, radiodermatitis, neutropenic fever, sepsis).
  • Adjuvant Phase Costs: Risk-adapted postoperative radiation or chemoradiotherapy for high-risk surgical features (e.g., positive margins, extranodal extension), and perioperative/adjuvant immunotherapy courses.
  • Surveillance & Follow-Up Phase Costs: Structured post-treatment surveillance visits, regular head and neck clinical exams, annual thyroid-stimulating hormone (TSH) endocrine screening, post-treatment baseline and surveillance imaging, and diagnostic panendoscopy for suspected recurrences.
  • Recurrence & Salvage Phase Costs: High-acuity costs associated with treating persistent or recurrent disease, including salvage laryngectomy or neck re-dissection, salvage re-irradiation, and second-line systemic therapies.

  • Travel, Transportation, and Displacement Costs: Expenses incurred by patients traveling long distances to specialized cancer centers, including direct transit costs, lodging/accommodation, and distance-related patient displacement.
  • Socioeconomic & Indirect Productivity Loss Costs: Indirect economic burdens resulting from wage/income loss, reduced working hours, disability or early retirement pensions, and productivity losses for family caregivers.
  • Institutional Care Delivery Costs: Cost variations across healthcare delivery settings, comparing certified specialized comprehensive cancer centers with non-certified facilities or high-volume versus low-volume regional hospitals.
  • Insurance, Co-payment, & Reimbursement Status Costs: Variance in out-of-pocket costs due to insurance coverage differences, patient co-payments, non-reimbursed health services, and differences between public national benefit coverage versus cash payment systems.

  • Oropharyngeal Cancer Costs: Costs tailored to treating the oropharynx (e.g., tonsil, base of tongue), including HPV-associated vs. non-HPV treatment strategies, transoral robotic surgery (TORS), transoral laser microsurgery (TLM), and dysphagia-related feeding tube management.
  • Laryngeal Cancer Costs: Costs associated with voice box preservation or removal, including total or partial laryngectomy, organ-preservation chemoradiotherapy, tracheostomy care, stoma management, and speech/voice prosthesis rehabilitation.
  • Hypopharyngeal Cancer Costs: Costs driven by aggressive subsite management, including laryngopharyngectomy, complex pharyngoplasty tissue reconstruction, and intensive management of severe swallowing dysfunction and soft-tissue necrosis.
  • Nasopharyngeal Cancer Costs: Non-surgical management costs characteristic of nasopharyngeal tumors, including primary definitive chemoradiotherapy, stereotactic re-irradiation, and long-term TSH/endocrine monitoring.
  • Oral Cavity & Mandibular Costs: Costs relating to jaw and mouth resections, including bone/soft-tissue resections, microvascular free-flap reconstruction (e.g., mandibulectomy), and specialized treatment for mandibular osteoradionecrosis (ORN).

  • Surgical Innovation Costs: Capital and procedural expenses for minimally invasive and reconstructive technologies, such as Transoral Robotic Surgery (TORS), Transoral Laser Microsurgery (TLM), and microvascular free-flap tissue transfers.
  • Advanced Radiation Delivery Costs: Technological expenses for conformal radiation techniques, including Intensity-Modulated Radiation Therapy (IMRT), Intensity-Modulated Proton Therapy (IMPT), Stereotactic Ablative Radiotherapy (SABR/SBRT), and brachytherapy.
  • Biologic & Novel Systemic Therapy Costs: High-cost novel agents, including immune checkpoint inhibitors (pembrolizumab, nivolumab), anti-EGFR targeted agents (cetuximab), antibody-drug conjugates (ADCs), and bispecific antibodies.
  • De-escalation & Treatment Optimization Costs: Costs associated with clinical trials and protocols evaluating reduced-dose radiation or de-intensified systemic therapy aimed at lowering long-term toxicity and overall care delivery costs.
  • Specialized Hyperbaric & Extended Medical Protocol Costs: Costs for specialized tissue-healing protocols, such as Hyperbaric Oxygen Therapy (HBOT) chamber sessions and long-term multi-drug oral PENTOCLO protocols for osteoradionecrosis.

  • Functional Rehabilitation Therapy Costs: Multi-professional functional rehabilitation, including speech and voice therapy, swallowing/dysphagia rehabilitation, occupational therapy, and physical therapy.
  • Long-Term Nutritional & Enteral Support Costs: Equipment and management costs for percutaneous endoscopic gastrostomy (PEG) tubes, nasogastric (NG) feeding tubes, and long-term registered dietitian nutritional care.
  • Dental & Oral Complication Care Costs: Ongoing dental maintenance costs, including management of radiation-induced xerostomia (dry mouth), trismus mouth-opening rehabilitation devices, and osteoradionecrosis care.
  • Psychosocial & Occupational Reintegration Costs: Expenses for psycho-oncological counseling, social work/case management, vocational rehabilitation, and occupational retraining programs.
  • Physical Symptom & Lymphedema Care Costs: Care for chronic physical sequelae, including lymphatic decompression therapy for neck lymphedema and fibrosis, chronic pain management, and audiology/hearing rehabilitation.

  • Multidisciplinary Tumor Board (MDT) & Team Coordination Costs: Administrative and clinical operational expenses for coordinating multidisciplinary care teams across head and neck surgery, radiation oncology, medical oncology, pathology, and supportive services.
  • Emergency Readmission & Acute Inpatient Management Costs: Unplanned health system costs arising from emergency admissions for severe treatment complications (e.g., neutropenic sepsis, uncontrolled pain, severe dehydration).
  • Cancer Center Certification & Facility Quality Costs: Operational overhead associated with maintaining certified specialized cancer center status, quality assurance standards, and high-volume facility infrastructure.
  • Clinical Trial Research & Administrative Costs: Institutional resources required to run research protocols, including investigator log time, protocol compliance monitoring, study coordinator support, and trial-specific imaging/biomarker collection.
  • Group Education & Digital Care Planning Costs: Health system innovations to optimize service delivery, such as waiting-list group speech and swallowing education sessions and electronic Holistic Needs Assessment (eHNA) care planning tools.

  • Palliative Symptom Management & Pharmacotherapy Costs: Pharmacological and supportive care costs for managing pain (opiate regimens), palliative systemic or targeted therapies, fatigue, and dyspnea.
  • Palliative Surgical & Procedural Intervention Costs: Surgical interventions performed strictly for symptom control, such as palliative tracheostomies for airway distress, palliative gastrostomy placement for severe dysphagia, and palliative tissue resections or mandibulectomies.
  • Hypofractionated Palliative Radiotherapy Costs: Delivery costs for short-course palliative radiation regimens (such as the QUAD SHOT regimen) designed to control local symptoms with minimal toxicity.
  • Hospice, Inpatient, & Home Palliative Care Costs: Interdisciplinary palliative care team consultations, inpatient hospice facility stays, and home-based palliative care addressing physical, psychological, social, and spiritual needs.
  • Advance Care Planning & Socio-Legal Support Costs: Administrative and social work support for living wills, healthcare power of attorney documentation, patient representative coordination, and socio-legal guidance for families.

PavelAndreev.ORG results:

Donor trust and the security of funds on the platform are our highest priority. Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Total you have donated

49.57M EUR

Regardless of its size, every donation helps save a human life or successfully carry out a social cause.

Total number of donations

1 497 541

The contribution of a large number of people reflects the commitment of our society and contributes to the success of the campaigns.

Number of active campaigns

665

Every campaign is a unique cause and offers an opportunity to bring about positive change in our society.

Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Start a campaign

Three important reasons to start a campaign on PavelAndreev.ORG

At PavelAndreev.ORG we use new technologies to let you support fundraising campaigns quickly and easily.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Cancer statistics in the United States

Start a campaign
Start a campaign

PavelAndreev.ORG is a crowdfunding platform for organizing fundraising donation campaigns to raise money, managed by Foundation Pavel Andreev (UIC: 206678629) with founder and CEO Pavel Andreev. All donations made through the fundraising platform PavelAndreev.ORG are administered by the team of Pavel Andreev and the Foundation Pavel Andreev.

Google News: PavelAndreev.ORG, Pavel Andreev.